Owens & Minor ROE 2006-2019 | OMI

Current and historical return on equity (ROE) values for Owens & Minor (OMI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Owens & Minor ROE for the three months ending June 30, 2019 was 5.53%.
Owens & Minor ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $-0.29B $0.50B -49.55%
2019-03-31 $-0.46B $0.50B -70.24%
2018-12-31 $-0.44B $0.52B -55.83%
2018-09-30 $-0.15B $0.79B -16.87%
2018-06-30 $-0.14B $0.80B -14.69%
2018-03-31 $0.06B $1.02B 6.15%
2017-12-31 $0.07B $1.02B 7.33%
2017-09-30 $0.08B $1.00B 7.84%
2017-06-30 $0.10B $0.99B 9.82%
2017-03-31 $0.10B $0.97B 10.53%
2016-12-31 $0.11B $0.96B 10.94%
2016-09-30 $0.11B $0.99B 11.35%
2016-06-30 $0.11B $1.00B 11.16%
2016-03-31 $0.11B $1.01B 10.91%
2015-12-31 $0.10B $0.99B 10.50%
2015-09-30 $0.09B $0.99B 8.67%
2015-06-30 $0.06B $0.98B 6.49%
2015-03-31 $0.06B $0.97B 6.00%
2014-12-31 $0.07B $0.99B 6.50%
2014-09-30 $0.08B $1.01B 7.81%
2014-06-30 $0.10B $1.03B 9.87%
2014-03-31 $0.11B $1.03B 10.85%
2013-12-31 $0.11B $1.03B 11.10%
2013-09-30 $0.11B $1.01B 10.94%
2013-06-30 $0.10B $0.99B 10.66%
2013-03-31 $0.11B $0.98B 10.88%
2012-12-31 $0.11B $0.97B 11.31%
2012-09-30 $0.11B $0.96B 11.37%
2012-06-30 $0.12B $0.95B 12.50%
2012-03-31 $0.12B $0.94B 12.58%
2011-12-31 $0.11B $0.92B 12.66%
2011-09-30 $0.11B $0.91B 12.65%
2011-06-30 $0.11B $0.90B 12.67%
2011-03-31 $0.11B $0.88B 12.97%
2010-12-31 $0.11B $0.86B 13.32%
2010-09-30 $0.12B $0.84B 15.05%
2010-06-30 $0.12B $0.82B 15.88%
2010-03-31 $0.12B $0.79B 15.75%
2009-12-31 $0.11B $0.77B 14.35%
2009-09-30 $0.09B $0.75B 12.93%
2009-06-30 $0.08B $0.71B 11.95%
2009-03-31 $0.08B $0.70B 12.19%
2008-12-31 $0.09B $0.69B 13.97%
2008-09-30 $0.10B $0.68B 14.69%
2008-06-30 $0.09B $0.66B 14.55%
2008-03-31 $0.09B $0.64B 14.07%
2007-12-31 $0.07B $0.61B 12.33%
2007-09-30 $0.06B $0.59B 10.05%
2007-06-30 $0.05B $0.57B 9.01%
2007-03-31 $0.04B $0.55B 7.71%
2006-12-31 $0.05B $0.55B 8.92%
2006-09-30 $0.06B $0.55B 10.76%
2006-06-30 $0.06B $0.53B 11.57%
2006-03-31 $0.07B $0.53B 13.02%
2005-12-31 $0.07B $0.51B 13.17%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.367B $9.839B
Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.719B 27.77
Medtronic (MDT) Ireland $146.698B 20.59
Stryker (SYK) United States $81.704B 28.25
Boston Scientific (BSX) United States $58.951B 28.59
Baxter (BAX) United States $44.709B 27.11
EssilorLuxottica Societe Anonyme (ESLOY) France $31.891B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.506B 18.24
Coloplast (CLPBY) Denmark $25.510B 40.72
Lonza Group Ag (LZAGY) Switzerland $25.282B 0.00
Terumo (TRUMY) Japan $22.900B 26.33
Smith & Nephew SNATS (SNN) United Kingdom $20.809B 0.00
ResMed (RMD) United States $19.242B 36.69
Sunny Optical Technology (SNPTF) China $16.157B 0.00
Bio-Rad Laboratories (BIO) United States $10.056B 53.91
Canopy Growth (CGC) Canada $9.869B 0.00
Insulet (PODD) United States $8.744B 518.11
Perrigo (PRGO) Ireland $7.581B 13.97
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.929B 20.66
Haemonetics (HAE) United States $6.450B 48.68
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.377B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.252B 0.00
Neogen (NEOG) United States $4.127B 68.52
NuVasive (NUVA) United States $3.399B 27.09
ICU Medical (ICUI) United States $3.395B 22.02
Hutchison China MediTech (HCM) China $2.815B 0.00
Quidel (QDEL) United States $2.690B 26.71
Agios Pharmaceuticals (AGIO) United States $2.149B 0.00
National Vision Holdings (EYE) United States $2.115B 45.66
Cardiovascular Systems (CSII) United States $1.821B 0.00
Aphria (APHA) $1.564B 0.00
VAREX IMAGING (VREX) United States $1.108B 25.54
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $0.984B 25.88
Omeros (OMER) United States $0.939B 0.00
Phibro Animal Health (PAHC) United States $0.903B 14.68
Eagle Pharmaceuticals (EGRX) United States $0.808B 20.61
NanoString Technologies (NSTG) United States $0.783B 0.00
Cerus (CERS) United States $0.741B 0.00
PetIQ (PETQ) United States $0.721B 17.04
LeMaitre Vascular (LMAT) United States $0.710B 42.06
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.642B 0.00
Surmodics (SRDX) United States $0.630B 119.69
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.467B 21.60
Meridian Bioscience (VIVO) United States $0.425B 13.27
BioLife Solutions (BLFS) United States $0.399B 131.13
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.385B 0.00
Utah Medical Products (UTMD) United States $0.369B 27.04
United Health Products (UEEC) United States $0.309B 0.00
Zynex (ZYXI) United States $0.305B 32.41
Bovie Medical (APYX) United States $0.243B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Vapotherm (VAPO) United States $0.173B 0.00
Fonar (FONR) United States $0.147B 10.43
Chimerix (CMRX) United States $0.145B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
InfuSystems Holdings (INFU) United States $0.105B 0.00
United-Guardian (UG) United States $0.087B 20.60
MRI Interventions (MRIC) United States $0.067B 0.00
Nephros (NEPH) United States $0.063B 0.00
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.034B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00